SC 13G | 2017-06-05 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 5,478,719 | 6.8% | EDGAR |
SC 13G/A | 2017-05-22 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 3,420,193 | 4.2% | EDGAR |
SC 13G | 2017-03-06 | D. E. SHAW & CO, L.P. | BIOCRYST PHARMACEUTICALS INC | 3,707,857 | 5.0% | EDGAR |
SC 13G/A | 2017-02-15 | RTW INVESTMENTS, LP | BIOCRYST PHARMACEUTICALS INC | 4,078,895 | 5.5% | EDGAR |
SC 13G/A | 2017-02-14 | VENROCK HEALTHCARE CAPITAL PARTNERS LP | BIOCRYST PHARMACEUTICALS INC | 7,226,246 | 9.8% | EDGAR |
SC 13G/A | 2017-02-14 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 3,237,734 | 4.4% | EDGAR |
SC 13G/A | 2017-01-19 | BlackRock Inc. | BIOCRYST PHARMACEUTICALS INC | 5,849,345 | 7.9% | EDGAR |
SC 13G | 2017-01-09 | D. E. SHAW & CO, L.P. | BIOCRYST PHARMACEUTICALS INC | 3,690,207 | 5.0% | EDGAR |
SC 13G | 2016-08-26 | RTW INVESTMENTS, LLC | BIOCRYST PHARMACEUTICALS INC | 3,701,460 | 5.0% | EDGAR |
SC 13G | 2016-08-22 | D. E. SHAW & CO, L.P. | BIOCRYST PHARMACEUTICALS INC | 3,740,239 | 5.1% | EDGAR |
SC 13G | 2016-08-17 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 11,038,944 | 15.0% | EDGAR |
SC 13D/A | 2016-08-16 | BAKER BROS. ADVISORS LP | BIOCRYST PHARMACEUTICALS INC | 11,038,944 | 15.0% | EDGAR |
SC 13G | 2016-08-12 | Flynn James E | BIOCRYST PHARMACEUTICALS INC | 4,896,741 | 6.6% | EDGAR |
SC 13G/A | 2016-04-11 | WELLINGTON MANAGEMENT GROUP LLP | BIOCRYST PHARMACEUTICALS INC | 1,496,859 | 2.0% | EDGAR |
SC 13G | 2016-03-28 | VENROCK HEALTHCARE CAPITAL PARTNERS LP | BIOCRYST PHARMACEUTICALS INC | 5,241,378 | 7.1% | EDGAR |
SC 13G | 2016-03-14 | D. E. SHAW & CO, L.P. | BIOCRYST PHARMACEUTICALS INC | 3,750,783 | 5.1% | EDGAR |
SC 13G/A | 2016-03-10 | FMR LLC | BIOCRYST PHARMACEUTICALS INC | 1,715,192 | 2.3% | EDGAR |
SC 13G/A | 2016-02-16 | RA CAPITAL MANAGEMENT, LLC | BIOCRYST PHARMACEUTICALS INC | 3,094,064 | 4.2% | EDGAR |
SC 13G/A | 2016-02-12 | FMR LLC | BIOCRYST PHARMACEUTICALS INC | 7,488,027 | 10.2% | EDGAR |
SC 13G/A | 2016-02-11 | WELLINGTON MANAGEMENT GROUP LLP | BIOCRYST PHARMACEUTICALS INC | 7,470,439 | 10.2% | EDGAR |